Browse > Article
http://dx.doi.org/10.7730/JSCM.2015.27.2.270

Neuroprotective Effects of Modified Yuldahanso-tang (MYH) in a Parkinson's Disease Mouse Model  

Go, Ga-Yeon (Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Daejeon Univercity)
Kim, Yoon-Ha (Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Daejeon Univercity)
Ahn, Taek-Won (Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Daejeon Univercity)
Publication Information
Journal of Sasang Constitutional Medicine / v.27, no.2, 2015 , pp. 270-287 More about this Journal
Abstract
Objectives To evaluate the neuroprotective effects of modified Yuldahanso-tang (MYH) in a Parkinson's disease mouse model. Methods 1) Four groups (each of 8 rats per group) were used in this study. 2) The neuroprotective effect of MYH was examined in a Parkinson's disease mouse model. C57BL/6 mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 30 mg/kg/day), intraperitoneal (i.p.) for 5 days. 3) The brains of 2 mice per group were removed and frozen at $-20^{\circ}C$, and the striatum-substantia nigra part was seperated. The protein volume was measured by Bradford method following Bio-Rad protein analyzing kit. Using mouse/Rat Dopamine ELISA Assay Kit. 4) The brains of 2 mice per group were separated and removed. TH-immunohistochemical was examined in the MPTP-induced Parkinson's disease mice to evaluate the neuroprotective effects of MYH on ST and SNpc. 5) Two mice out of each group were anesthetized and skulls were opened from occipital to frontal direction to take out the brains. The brains added TTC solution for 20 minutes for staining. 6) The water tank used for morris water maze test was filled with $28^{\circ}C$ water, and a round platform of 10cm in diameter was installed for mice to step on. The study was carried out once a day within 30 seconds, keep exercising to step on the platform in the pool. 7) The brains of two mice out of each group were fixed in 10% formaldehyde solution and paraphillin substance was infiltrated. They were fragmented by microtome, and observed under an optical microscope after Hematoxylin & Eosin staining. 8) A round acrylic cylinder with its upper side open was filled with clean water and depressive mouse models were forced to swim for 15 minutes. After 24 hours the animals were put in the same equipment for 5 minutes and were forced to swim. 9) The convenient, simple, and accurate high-performance liquid chromatography (HPLC) method was established for simultaneous determination of Neurotransmitters in MPTP-MYH group. Results 1) MYH possess Dopamine cell protective effect on MPTP-induced injury in striatum and substantia nigra pars compacta. 2) MYH inhibits the loss of tyrosine hydroxylase-immunoreacitive (TH-IR) cells in the striatum and substantia nigra pars compacta on MPTP-induced injury in C57BL/6 mice. 3) MYH possesses improvement effect on MPTP-induced memory deterioration in C57BL/6 mice through the reduction of prolongated Sort of lost time by MPTP injection using the Morris water maze test. 4) MYH possesses hippocampal neuron protective effect on MPTP-induced injury in C57BL/6 mice. 5) MYH possesses improvement effect on MPTP-induced motor behaviour deficits and depression in C57BL/6 mice through the reduction of prolongated losing motion by MPTP injection using the Forced swimming test. 6) MYH increases serotonin product amount on MPTP-induced injury in C57BL/6 mice. Conclusions This experiment suggests that the neuroprotective effect of MYH is mediated by the increase in Dopamin, TH-ir cell, Hippocampus and Serotonin. Furthermore, MYH essential oil may serve as a potential preventive or therapeutic agent regarding Parkinson's disease.
Keywords
Modified Yuldahanso-tang (MYH); Parkinson' disease; Dopamin; TH-ir cell; Hippocampus; Serotonin;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: A systematic review and meta-analysis. Movement disorders:official journal of the Movement Disorder Society. 2014.
2 Lee HJ. Characteristic of attention and frontal executive function in patients with Parkinson's disease and Parkinson's disease dementia and Sleep Quality. Kyungbuk university.2013:13.
3 Ahn SA. Direct medical costs for patients with parkinson's disease : based on national patients sample for the national health insurance claims data. Graduate School of Sungkyunkwan University Master's thesis. 2014:14.
4 Hubert H. Updates in the medical management of Parkinson's disease. medical grand rounds. cleveland clinic journal of medicine. 2012;79(1):28-35.   DOI
5 Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F et al. Deletionof crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet.2000;24(4):415-9.   DOI
6 Hong WG. Jungkyohwangjenaekyeong. Seoul: Dongyang euihak yeonkuwon choolpanboo. 1995:23-5, 39-40, 119, 303-4.
7 Park SM, Lee SH, Yin CS, Kang MK, Lee YH. Literature Review on Parkinson's disease in Oriental medicine. J. Korean acupuncture & Moxibustion Society. 2004;21(1):202-210.
8 Lee JM. Dongeuisoosebowonsasangbonchokwon. Seoul: Eulyumoonhwasa. 2002:27-278.
9 Bas NY. Neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement on Parkinsonian model. Graduate School of Daejeon University Master's thesis. 2011:1-110.
10 Kim HJ, Bas NY, Jang MH, Yang HO, Ahn TW. Autophagy inducing Effect of modified Yeoldahansotang and its related Proteins in SH-SY5Y cells. J Sasang Constitut Med. 2013;25(3):208-217.   DOI
11 Choi JS, Jang MH, Ahn TW. A Case Study of Parkinson's Disease Patient Treated with Yuldahansotang gagam. J Sasang Constitut Med. 2012;24(3):104-113.   DOI   ScienceOn
12 BR Perri, DH Smith, H Murai, G Sinson, KE Saatman, R Raghupathl et al. Metabolic Quantification of Lesion Volume following Experimental Traumatic Brain Injury in the Rat. Journal of Neurotrauma. 1997;14:15-22.   DOI
13 Vosselera M., N. Abegunewardenea, N. Hoffmannb, S.E. Petersene, D. Beckera, D. Cleppienbet al. Area at Risk and Viability after Myocardial Ischemia and Reperfusion Can Be Determined by Contrast-Enhanced Cardiac Magnetic Resonance Imaging. Eur Surg Res. 2009;43:13-23.   DOI
14 Kasper, Braunwald, Fauci, Hauser, Longo, Jameson. Harrison's Principles of Internal medicine. 16th edition. Seoul: MIP. 2006:2631-2638.
15 Han JT. Activated microglia exacerbate dopaminergic neuronal degeneration in Parkinsonian animal model. Eulji university. 2012:12-3.
16 Sun, L., Xu, S., Zhou, M., Wang, C., Wu, Y., Chan, P. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice. Brain Research. 2010;1335:74-82.   DOI
17 Widdowson PS, Farnworth MJ, Upton R., Simpson MG. No changes in behavior, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rat. Human and Experomental Toxicology. 1996;15(7): 583-591.   DOI
18 Ferger, B., Teismann, P., Earl, C,D., Kuschinsky, K., Oertel, W.H. The propective effects of PBN against MPTP toxocity are independent of hydroxyl radical trapping. Phamaco Biochem Behav. 2000;65(3):425-431.   DOI
19 Westm B.D., Sheghrue, P.J., Vanko, A.E.H,, Ransorn, R.W. Kinney, G.G. Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment. Pharmacol. Biochm. Behav 2006;84(1):158-161.   DOI
20 The National College of Oriental Medicine Bonchohak Professor Co-ed : Bonchohak. Seoul: Younglimsa. 1992:129,132,148,151,178.
21 Jung WS. A study on the alteration of general characteristics and therapeutic effect of GamiYeoldahansotang (加味熱多寒少湯) in patients with Atopic Dermatitis. Graduate School of Kyunghee University Master's thesis. 2002:14.
22 Ravikumar B, Berger Z, Vacher C, O'Kane C. J, Rubinsztein D. C. Rapamycin pre-treatment protects against apoptosis. Human Molecular Genetics. 2008;7:1209-1216.   DOI
23 Cell signaling Technology (http://www.cellsignal.com/pathways/autophagy-signaling.jsp)
24 Slomovitz B. M, Coleman R. L. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res. 2012;21:5856-64.
25 Sung Joon Kim, Jin Chul Yoo, Hong Sung Jeon, Jae Seong Kim, Seungactivity in rat brain synaptosomes: Kim, Myong Hwa Sim, et al. Development and application of tyrosine hydroxylase gene and neurotrophic factor inducible material screening from medicinal herbs for prevent of neuronal cell degradation. Chosun University. 2007.
26 Jaclyn L. P, Gideon M. B, Wendy B. B, Phillip A. D. Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resistance Updates. 2008;32-50.
27 Sebastian A, Antje S. L, Sebastian W, Bjorn S. Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks. MCB. 2011;06159-11.
28 Messripour, M. and Clark, J. B. : Tyrosine hydroxylase Direct mesurment using high performance liquid chromatography. J. Neurochem. 1982;38:1139-43.   DOI
29 Lee TH, Lee EY. Effect of Daekumeumja Herb-acupuncture on c-Fos Expression in Hippocampus of Alcohol Intoxicated Rats. The Journal of Korean Acupuncture & Moxibustion Society. 2006;23(3):43
30 Cummings JL. Depression in Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454.   DOI
31 Fetoni V, Soliveri P, Monza D, Testa D, Girotti F. Affective symptoms in multiple system atropy and Parkinson's disease : response to levodopa therapy. J Neurol Neurosurg Psychiatry. 1999;66:541-544.   DOI
32 Burn DJ. Depression in Parkinson's disease. c9. 2002:44-54.
33 Go GY, Kim YH, Ahn TW. Neuroprotective Effects of Hyangsayangwi-tang in MPTP-induced Mouse Model of Parkinson's Disease. 2014;26(2):176.   DOI
34 Seo JH, Shin MS, Kim CJ, Lee KS, lim BB. The influence of treadmill exercise in hot environments about serotonin expression in the rat brain, generating neurons and short-term memory. Korean Journal of Sport Science. 2009;20(4);744.